Lack of impact of ipragliflozin on endothelial function in patients with type 2 diabetes: sub-analysis of the PROTECT study

BACKGROUND: We assessed the impact of 24 months of treatment with ipragliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, on endothelial function in patients with type 2 diabetes as a sub-analysis of the PROTECT study. METHODS: In the PROTECT study, patients were randomized to receive eit...

Descripción completa

Detalles Bibliográficos
Autores principales: Kishimoto, Shinji, Higashi, Yukihito, Imai, Takumi, Eguchi, Kazuo, Fukumoto, Kazuo, Tomiyama, Hirofumi, Maemura, Koji, Tanaka, Atsushi, Node, Koichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199575/
https://www.ncbi.nlm.nih.gov/pubmed/37210524
http://dx.doi.org/10.1186/s12933-023-01856-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199575/
https://www.ncbi.nlm.nih.gov/pubmed/37210524
http://dx.doi.org/10.1186/s12933-023-01856-x

Ejemplares similares